A US Patient Perspective on the Diagnosis and Burden of AxSpA

Sponsored by Novartis Medical Affairs

Nov 01, 2024 9:00 am

Click to download or view mobile version

Presentation

Marina N. Magrey, MD

Author(s):

Abstract or description:

More Virtual Posters

AbbVie March 2025

Long-term maintenance of response of an IL-23i in PsA

AbbVie March 2025

Time to first musculoskeletal response of an IL-23i in PsA

Sanofi RNL Poster

Effectiveness of Interleukin-6 Receptor Inhibitors versus Conventional Synthetic Immunomodulatory Therapy for Treatment of Frail Patients with Polymyalgia Rheumatica

Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

Presentation

Marina N. Magrey, MD

Author(s):

Abstract or description:

×